Drug Type Small molecule drug |
Synonyms CLX 16214, CLX1624 |
Target |
Mechanism α-adrenergic receptor agonists(Alpha adrenergic receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Blepharoptosis | Preclinical | IN | 01 Jul 2024 |